Search research articles
Contact Us
Filters
Showing results (131-140 of 147) with videos related to
Page
of 15
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 14, 1997
Metabolic profiles of montelukast sodium (Singulair), a potent cysteinyl leukotriene1 receptor antagonist, in human plasma and bile
S K Balani, X Xu, V Pratha, et al.
Molecular Psychiatry
|
March 19, 2024
Microglial over-pruning of synapses during development in autism-associated SCN2A-deficient mice and human cerebral organoids
Jiaxiang Wu, Jingliang Zhang, Xiaoling Chen, et al.
Journal of the International Association of Providers of AIDS Care
|
November 29, 2021
Provider and Patient Perspectives of Rapid ART Initiation and Streamlined HIV Care: Qualitative Insights From Eastern African Communities
Florence Mwangwa, Monica Getahun, Harriet Itiakorit, et al.
Biorxiv : the Preprint Server for Biology
|
March 17, 2025
Restoration of excitation/inhibition balance enhances neuronal signal-to-noise ratio and rescues social deficits in autism-associated <i>Scn2a-</i>deficiency
Jingliang Zhang, Muriel Eaton, Xiaoling Chen, et al.
AIDS and Behavior
|
January 20, 2020
Understanding Demand for PrEP and Early Experiences of PrEP Use Among Young Adults in Rural Kenya and Uganda: A Qualitative Study
Carol S Camlin, Catherine A Koss, Monica Getahun, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 29, 2005
5-Heteroatom-substituted pyrazoles as canine COX-2 inhibitors: Part 2. Structure-activity relationship studies of 5-alkylethers and 5-thioethers
Subas M Sakya, Hengmiao Cheng, Kristin M Lundy Demello, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 9, 2005
5-heteroatom substituted pyrazoles as canine COX-2 inhibitors. Part 1: Structure-activity relationship studies of 5-alkylamino pyrazoles and discovery of a potent, selective, and orally active analog
Subas M Sakya, Kristin M Lundy DeMello, Martha L Minich, et al.
AIDS Patient Care and Stds
|
October 6, 2022
Providers' Attitudes and Experiences with Pre-Exposure Prophylaxis Implementation in a Population-Based Study in Kenya and Uganda
Carol S Camlin, Monica Getahun, Catherine A Koss, et al.
Open Forum Infectious Diseases
|
September 4, 2024
First Case of HIV Seroconversion With Integrase Resistance Mutations on Long-Acting Cabotegravir for Prevention in Routine Care
Catherine A Koss, Monica Gandhi, Elias K Halvas, et al.
Plos Medicine
|
February 9, 2021
HIV incidence after pre-exposure prophylaxis initiation among women and men at elevated HIV risk: A population-based study in rural Kenya and Uganda
Catherine A Koss, Diane V Havlir, James Ayieko, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 147) with videos related to
Sort By:
Page
of 15
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 14, 1997
Metabolic profiles of montelukast sodium (Singulair), a potent cysteinyl leukotriene1 receptor antagonist, in human plasma and bile
S K Balani, X Xu, V Pratha, et al.
Molecular Psychiatry
|
March 19, 2024
Microglial over-pruning of synapses during development in autism-associated SCN2A-deficient mice and human cerebral organoids
Jiaxiang Wu, Jingliang Zhang, Xiaoling Chen, et al.
Journal of the International Association of Providers of AIDS Care
|
November 29, 2021
Provider and Patient Perspectives of Rapid ART Initiation and Streamlined HIV Care: Qualitative Insights From Eastern African Communities
Florence Mwangwa, Monica Getahun, Harriet Itiakorit, et al.
Biorxiv : the Preprint Server for Biology
|
March 17, 2025
Restoration of excitation/inhibition balance enhances neuronal signal-to-noise ratio and rescues social deficits in autism-associated <i>Scn2a-</i>deficiency
Jingliang Zhang, Muriel Eaton, Xiaoling Chen, et al.
AIDS and Behavior
|
January 20, 2020
Understanding Demand for PrEP and Early Experiences of PrEP Use Among Young Adults in Rural Kenya and Uganda: A Qualitative Study
Carol S Camlin, Catherine A Koss, Monica Getahun, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 29, 2005
5-Heteroatom-substituted pyrazoles as canine COX-2 inhibitors: Part 2. Structure-activity relationship studies of 5-alkylethers and 5-thioethers
Subas M Sakya, Hengmiao Cheng, Kristin M Lundy Demello, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 9, 2005
5-heteroatom substituted pyrazoles as canine COX-2 inhibitors. Part 1: Structure-activity relationship studies of 5-alkylamino pyrazoles and discovery of a potent, selective, and orally active analog
Subas M Sakya, Kristin M Lundy DeMello, Martha L Minich, et al.
AIDS Patient Care and Stds
|
October 6, 2022
Providers' Attitudes and Experiences with Pre-Exposure Prophylaxis Implementation in a Population-Based Study in Kenya and Uganda
Carol S Camlin, Monica Getahun, Catherine A Koss, et al.
Open Forum Infectious Diseases
|
September 4, 2024
First Case of HIV Seroconversion With Integrase Resistance Mutations on Long-Acting Cabotegravir for Prevention in Routine Care
Catherine A Koss, Monica Gandhi, Elias K Halvas, et al.
Plos Medicine
|
February 9, 2021
HIV incidence after pre-exposure prophylaxis initiation among women and men at elevated HIV risk: A population-based study in rural Kenya and Uganda
Catherine A Koss, Diane V Havlir, James Ayieko, et al.
Page
of 15